granisetron serotonin receptor antagonist used antiemetic treat nausea vomiting following chemotherapy radiotherapy main effect reduce activity vagus nerve nerve activates vomiting center medulla oblongata much effect vomiting due motion sickness drug effect dopamine receptors muscarinic receptors granisetron developed chemists working british drug company beecham c available generic produced roche laboratories trade name kytril drug approved united kingdom united states fda granisetron transdermal patch trade name sancuso approved us fda september sancuso manufactured drug delivery systems kyowa kirin inc patented approved medical use world health organizations list essential may used chemotherapyinduced nausea vomiting appears work common sideeffects chemotherapy treatment nausea vomiting diarrhea one type drug doctor prescribe prevent lessen relieve discomfortcitation needed number medications including granisetron appear effective controlling postoperative nausea vomiting unclear less effective agents droperidol metoclopramide granisetron patch sancuso studied use though fda approved granisetron welltolerated drug side effects headache dizziness constipation commonly reported side effects associated use significant drug interactions reported drugs use broken livers cytochrome system little effect metabolism drugs broken systemcitation needed extended release injectable version granisetron known sustol also available united states long acting form used treatment acute delayed cinv moderately emetogenic chemotherapy anthrocycline andor cyclophosphamide ac highly emetogenic regimens review fda grant broad hec label drug citing focus ac regimens primarily breastcancer lack httpsenwikipediaorgwikigranisetron